April 27, 2021
Nihon Generic said on April 26 that it has initiated a Class II voluntary recall for certain lots of its metformin diabetes drug after detecting a level of the cancer-causing impurity N-nitrosodimethylamine (NDMA) that exceeds the limit set by the...read more